Clinical Trials Logo

Clinical Trial Summary

Retrospective Post-Market Clinical Follow Up of Rotarex®S & Aspirex®S Catheters in treating thrombotic occlusion of Arteriovenous Graft for dialysis access (Artificial Bypass)


Clinical Trial Description

To evaluate the safety, technical performance, and clinical efficacy of the Rotarex®S & Aspirex®S Catheters as a stand-alone and adjunctive therapy for the treatment of acute thrombotic occlusion of arteriovenous graft for dialysis access (Artificial Bypass) in accordance with Rotarex®S & Aspirex®S Catheters intended use. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05071872
Study type Observational
Source Straub Medical AG
Contact Torsten Böhler, Dr.
Phone 81 720 05 12
Email [email protected]
Status Recruiting
Phase
Start date October 2021
Completion date March 2022

See also
  Status Clinical Trial Phase
Recruiting NCT04494035 - AVATR - Arteriovenous Access Thrombosis Removal With CAPERE Thrombectomy System N/A
Completed NCT03839264 - Optimal Screening Program in Detecting Stenosis and Predicting Thrombosis in Hemodialysis Graft